Quick Answer: A practical terpene effects chart for formulators should focus on mechanism, thermal stability, documented effects, and format compatibility, not just aroma labels like ‘relaxing’ or ‘uplifting.’
In most cannabis formulations, β-caryophyllene, linalool, limonene, myrcene, humulene, α-pinene, terpinolene, and ocimene form the core decision set. Sesquiterpenes like β-caryophyllene and humulene are more heat-stable and survive vape, concentrate, and edible processing better, while monoterpenes like myrcene, limonene, pinene, and ocimene are more volatile and best preserved in low-temperature applications.
The right terpene profile is chosen by matching product format first, then aligning receptor activity and effect direction with the intended product experience.
Key Takeaways
- Many terpene references are either too simplified for consumers or too technical for formulators, leaving product developers without practical guidance for selecting terpene profiles during formulation.
- Eight core terpenes anchor most cannabis formulations—β-caryophyllene, linalool, limonene, myrcene, humulene, α-pinene, terpinolene, and ocimene—each contributing distinct mechanisms, effects, and thermal stability considerations.
- β-caryophyllene is unique because it directly activates CB2 receptors, providing anti-inflammatory and analgesic effects while remaining non-psychoactive and highly stable during high-temperature processing.
- Monoterpenes like limonene, myrcene, and pinene drive fast aroma and immediate effects, but their lower boiling points mean they often degrade during high-temperature extraction, baking, or vape hardware operation.
- Sesquiterpenes such as β-caryophyllene and humulene are more thermally stable, allowing them to survive decarboxylation, concentrate processing, and vape temperatures where many monoterpenes volatilize.
- Shop sample kits today from Terpene Belt Farms to see what quality terpenes backed by detailed COAs and trace-compound terpene data for consistent product formulation.
Every formulator who’s gone looking for a terpene reference has run into the same problem. The consumer-facing charts tell you a terpene smells like pine and makes you feel “uplifted.” The academic papers go in the opposite direction and present raw receptor binding data with no practical context for what that means in a vape cart or a gummy. Neither one actually helps you make a product decision.
The gap between those two extremes is where most formulation errors happen. Profiles get selected because the aroma fits the branding, not because the terpene profile is compatible with the production process. Or a formulator builds a sedation-positioned product around a high-linalool CDT and then runs it through a high-temperature mixing process, losing most of the linalool before the product ever reaches a consumer. Or two terpenes get picked individually based on their effect profiles without considering whether they interact in a meaningful way when combined.
This reference covers the eight terpenes that anchor most cannabis formulations, organized around the four variables that actually matter at the bench: receptor mechanism, documented effects, thermal stability, and format compatibility. After those eight, there’s an extended chart covering ten additional cannabis terpenes that appear regularly in CDT COAs and are increasingly relevant as brands move toward terpene-transparent product positioning
8 Common Terpenes in Most Formulations
Most cannabis terpene profiles are built around a small core of compounds that appear consistently across cultivars and carry the strongest research basis. The eight terpenes below represent that core.
1. B-Caryophyllene
β-Caryophyllene occupies a category of its own in cannabis chemistry. It is the only terpene in cannabis that functions as a direct agonist of the CB2 cannabinoid receptor.
| Property | Detail |
| Class | Sesquiterpene |
| Boiling Point | ~310°C |
| Primary Mechanism | CB2 receptor agonist, PPAR-γ activity |
| Key Effects | Anti-inflammatory, analgesic, anxiolytic |
| Format Stability | High — vape, concentrate, topical, edibles |
| Aroma | Pepper, woody, spice |
Research published in PNAS confirmed that (E)-β-caryophyllene selectively binds CB2 at a Ki of 155 nM and produces cannabimimetic anti-inflammatory effects in vivo, which led to its classification as a dietary cannabinoid.
This is a designation no other terpene currently holds. This CB2 activity is relevant for formulators because it means β-caryophyllene is adding pharmacological activity that goes beyond aroma, without engaging the CB1 receptor and without producing psychoactive effects.
From a formulation standpoint, its ~310°C boiling point makes it the most thermally stable major terpene in cannabis. It survives high-temp concentrate processing, standard vape hardware temperatures, decarboxylation, and baking, which is why it remains present in finished products where most monoterpenes have already degraded.
It pairs well with limonene for a combined anti-inflammatory and mood-supporting profile, and with humulene for compounded NF-κB-pathway anti-inflammatory activity.
For a CDT profile that leads with β-caryophyllene across a broad range of formats, Citrus #144 delivers caryophyllene at 11.37% alongside α-humulene at 4.19%, with limonene (18.77%) and myrcene (11.73%) rounding out a profile that covers CB2 agonism, adenosine pathway activity, and GABA modulation across a single oil.
2. Linalool
Linalool’s anxiolytic activity runs through the GABAergic system. Research published in Frontiers in Behavioral Neuroscience demonstrated that linalool odor exposure produced significant anxiolytic effects in mice that were blocked by flumazenil, a benzodiazepine receptor antagonist, establishing that GABA-A transmission via benzodiazepine-responsive receptors is central to how linalool produces calming effects.
| Property | Detail |
| Class | Monoterpene alcohol |
| Boiling Point | ~198°C |
| Primary Mechanism | GABA-A modulator, NMDA receptor antagonist |
| Key Effects | Anxiolytic, sedative |
| Format Stability | Moderate — tincture, low-temp vape, topical |
| Aroma | Floral, lavender |
This GABA mechanism is additive with myrcene’s sedative activity, which is why linalool + myrcene profiles tend to produce more pronounced sedative outcomes than either terpene alone.
The formulation constraint with linalool is real: its ~198°C boiling point puts it within range of most vape hardware operating temperatures, meaning you can lose meaningful concentration during production or use if temperatures aren’t controlled.
High-linalool CDTs are well-suited for tinctures, low-temp vape formulations, and topicals where heat exposure is minimal. For high-temp concentrate or edible applications, expect significant linalool degradation and plan accordingly rather than relying on the label concentration in your finished product calculations.
3. Limonene
Limonene‘s mechanism centers on adenosine A2A receptor activation, which drives increases in dopamine and GABA concentrations in the striatum.
| Property | Detail |
| Class | Monoterpene |
| Boiling Point | ~176°C |
| Primary Mechanism | Adenosine A2A receptor activity, dopamine pathway modulation |
| Key Effects | Mood elevation, anti-anxiety, anti-inflammatory |
| Format Stability | Moderate — vape, beverage, edibles |
| Aroma | Citrus peel, lemon |
In a 2024 double-blind, placebo-controlled crossover study from Johns Hopkins University and the University of Colorado, 20 healthy adults who inhaled vaporized limonene alongside THC showed significantly reduced anxiety compared to those receiving THC alone, providing the clearest human clinical evidence to date that terpene-cannabinoid interaction is real and measurable.
This is the most significant clinical study of the entourage effect published to date, and limonene is the terpene at its center.
For formulators, limonene’s moderate boiling point (~176°C) means it performs well in vape applications at standard temperatures, in properly emulsified beverages, and in edibles where processing temps stay below 175°C. It degrades in high-temp baking applications, so edibles formulated at 350°F+ will lose most of their limonene before the product reaches the consumer.
2024 Fruit #135 is a profile built around this mechanism: limonene at 24.04% leads the adenosine A2A and dopamine activity, β-caryophyllene at 15.13% adds CB2 grounding, and α-pinene at 5.23% introduces an AChE inhibition layer that keeps the profile from reading as purely mood-forward. It is one of the more versatile CDT options for vape, tincture, or beverage applications.
4. Myrcene
Myrcene is consistently the most abundant terpene in cannabis, and also one of the most misunderstood in formulation contexts. Its sedative and analgesic character comes from GABA pathway enhancement and adenosine A2A receptor modulation.
| Property | Detail |
| Class | Monoterpene |
| Boiling Point | ~167°C |
| Primary Mechanism | GABA enhancement, adenosine A2A receptor modulation |
| Key Effects | Sedation, analgesia, muscle relaxation |
| Format Stability | Low — degrades above 200°C |
| Aroma | Earthy, musky, herbal |
Research suggests myrcene can reduce nociception in preclinical models through mechanisms involving adenosine receptors and TRPV1 channel activation, making it one of the more pharmacologically active monoterpenes in terms of body-effect contribution to cannabis products.
The critical formulation note is its volatility. Myrcene begins to degrade around 167°C and losses accelerate sharply above 200°C. Most concentrate processing, decarboxylation, and standard vape coil temperatures sit in or above that range. Formulators building high-myrcene products should plan for re-addition of terpenes post-extraction rather than relying on preserved native myrcene to deliver the intended effect profile.
When you need myrcene’s sedative character alongside thermal processing, pairing it with a high sesquiterpene CDT gives you the aromatic anchor of myrcene while the caryophyllene and humulene carry the anti-inflammatory activity through heat.
Gas #707 does exactly this: myrcene leads at 27.42%, but the profile is grounded by β-caryophyllene (10.95%) and α-humulene (3.50%) — two sesquiterpenes that survive processing temperatures and continue contributing CB2 and NF-κB activity in finished products even when some of the myrcene has volatilized.
5. Humulene
Humulene is one of the most underutilized anti-inflammatory terpenes in cannabis formulation. It functions as an NF-κB pathway inhibitor and COX-2 suppressor, a mechanism similar to conventional NSAIDs, and its anti-inflammatory effects have been measured as comparable to dexamethasone in some preclinical models.
| Property | Detail |
| Class | Sesquiterpene |
| Boiling Point | High effective stability (sesquiterpene class) |
| Primary Mechanism | NF-κB pathway inhibitor, COX-2 suppressor |
| Key Effects | Anti-inflammatory, appetite suppression |
| Format Stability | High — concentrates, vape |
| Aroma | Earthy, woody, herbal |
Research published in the European Journal of Pharmacology demonstrated that α-humulene, when administered orally to rodents, reduced TNF-α, IL-1β, COX-2 expression, and carrageenan-induced edema through NF-κB suppression. Those are meaningful signals for a terpene that most formulators treat as a minor aromatic contributor.
As a sesquiterpene, humulene is thermally stable and performs well in concentrate and vape formats where monoterpenes are partially or fully lost. It doesn’t hold CB2 receptor activity the way β-caryophyllene does — the ring structure that makes β-caryophyllene a CB2 agonist is absent in humulene — but its NF-κB inhibition creates compounded anti-inflammatory activity when the two terpenes appear together, as they do in CDT profiles like Gas #707 and Citrus #144.
6. A-Pinene
α-Pinene’s most clinically significant property may be its acetylcholinesterase inhibition. AChE inhibition prevents the breakdown of acetylcholine, the neurotransmitter associated with memory and cognitive function.
| Property | Detail |
| Class | Monoterpene |
| Boiling Point | ~155°C |
| Primary Mechanism | Acetylcholinesterase (AChE) inhibitor, bronchodilator |
| Key Effects | Alertness, memory support, anti-inflammatory |
| Format Stability | Moderate — inhalation, tincture |
| Aroma | Pine, fresh, woody |
ScienceDirect data on pinene pharmacology notes that its acetylcholinesterase inhibition has an IC50 of 0.44 mM, and this mechanism is the same target used by pharmaceutical treatments for dementia. For formulators, this means high-pinene profiles have a genuinely distinct cognitive character compared to myrcene or linalool-dominant profiles. It maps to alertness and memory retention rather than sedation or anxiety reduction.
Pinene also functions as a bronchodilator, which has specific relevance for inhalation formats. Pairing pinene with linalool produces a combination that adds alertness-supportive AChE inhibition on top of linalool’s GABA modulation, potentially producing a clearer-headed relaxation compared to myrcene + linalool profiles that tend to run more sedative.
2023 Sweet #16 (Myrcene 23.84%, α-Pinene 20.05%, Limonene 12.12%) applies this logic directly. High α-pinene at 20.05% brings strong AChE inhibition alongside myrcene’s GABA activity.
The limonene adds adenosine A2A and dopamine support on top. For brands trying to differentiate a “relaxed but functional” position from a pure night-time formula, profiles with this myrcene/pinene balance are worth testing. For more details on how inhalation-format terpene ratios interact with hardware and dosing, check out our R&D vape formulation best practices guide.
7. Terpinolene
Terpinolene is one of the most distinctive-smelling terpenes in cannabis and also one of the least understood pharmacologically compared to the others on this list.
| Property | Detail |
| Class | Monoterpene |
| Boiling Point | ~186°C |
| Primary Mechanism | Antioxidant pathway |
| Key Effects | Antioxidant, mild sedation at higher concentrations |
| Format Stability | Low-moderate — flower, low-temp inhalation |
| Aroma | Citrus, floral, herbal, pine (multi-dimensional) |
Its antioxidant activity is documented, and some research suggests mild sedative properties at higher concentrations, but it does not have a confirmed direct receptor pathway of the kind that β-caryophyllene or linalool do. That matters for formulators making effect claims: terpinolene can be accurately positioned around its antioxidant character and its aromatic complexity, but stronger effect claims require more clinical backing than currently exists.
What terpinolene does well is differentiation. High-terpinolene CDT profiles have a distinctive “sativa” character associated with Durban Poison, Jack Herer, and similar cultivar lineages.
It’s a complex citrus-pine-floral top note that reads as brighter and more cerebral than myrcene-heavy profiles. Its low-to-moderate boiling point means it performs best in low-temp vape and flower-infusion applications, where its volatile aromatics are preserved for delivery.
8. Ocimene
| Property | Detail |
| Class | Monoterpene |
| Boiling Point | ~50–66°C |
| Primary Mechanism | Antifungal/antiviral pathways |
| Key Effects | Antifungal, antiviral, decongestant |
| Format Stability | Very low — low-temp inhalation only |
| Aroma | Sweet, herbal, floral |
Ocimene is the most volatile major terpene in cannabis by a significant margin. Its boiling point range of 50–66°C means it begins volatilizing at or below room temperature and is among the first compounds to degrade in any heated application.
High-ocimene profiles require careful packaging management, sealed glass or airtight PTFE-compatible containers, minimal headspace, and cold storage, and should generally be reserved for low-temp inhalation or room-temperature applications where that volatility is an asset rather than a liability.
Its functional properties involve antifungal and antiviral pathways. The functional evidence for ocimene is less robust than for β-caryophyllene, linalool, limonene, or myrcene, so formulators should treat it primarily as an aromatic contributor and be cautious about leading with effect claims without more clinical support.
Where ocimene earns its place is in profiles targeting bright, sweet, herbal aromatics. It contributes complexity that other terpenes cannot replicate, and in the right low-temp application, it shows up fully.
10 Additional Cannabis Terpenes Worth Knowing
The eight terpenes above are the workhorses of most cannabis formulations, but CDT profiles contain a much wider cast of compounds. The terpenes below appear regularly in COA data, contribute meaningfully to aroma and effect, and are increasingly relevant as brands build terpene-transparent product lines.
| Terpene | Aroma | Mechanism / Activity | Boiling Point | Formulation Note |
| Bisabolol | Floral, sweet | Anti-inflammatory via NF-κB/AP-1 inhibition | ~153°C | Strong topical/cosmetic use case; low skin irritancy |
| Camphene | Earthy, woody | Antioxidant; possible cardiovascular effects | ~159°C | Low % in most CDTs; contributes to piney-woody base notes |
| Geraniol | Floral, rose | Antifungal, neuroprotective potential | ~230°C | High thermal stability; useful for floral-forward profiles in vape and beverage |
| Borneol | Camphor, minty | Anti-inflammatory, potential CNS activity | ~213°C | Used in topicals; limited inhalation data |
| Sabinene | Spicy, woody | Antioxidant, mild antimicrobial | ~163°C | Minor terpene; contributes to OG/Kush base note complexity |
| Guaiol | Pine, rose | Antimicrobial, mild anti-inflammatory | ~166°C | Occasionally detected in CDTs at low concentration |
| Valencene | Citrus, orange | Antifungal, anti-inflammatory | ~254°C | High thermal stability; strong citrus character for beverage and vape |
| Phytol | Grassy, floral | Anxiolytic, sedative (GABA pathway) | ~203°C | Diterpene; appears in full-spectrum extracts; low-volatility contributor |
| Nerolidol | Floral, woody | Sedative, antimicrobial | ~122°C | Useful as a topical penetration enhancer; performs in low-temp vape |
| p-Cymene | Spicy, citrus | Antifungal, analgesic via TRPV1 | ~177°C | Common in sativa-leaning CDT profiles; moderate thermal tolerance |
The presence of these terpenes, even at trace concentrations, is evident in the dense minor peak patterns observed in GC-MS chromatograms of CDT profiles. Those peaks represent compounds with their own pharmacological activity. A botanical blend copies the five largest peaks. A CDT carries all of them, and that difference shows up in finished product behavior.
How to Use This Chart to Select CDT Profiles
The chart data above is most useful when applied in a specific order at the formulation stage. Starting with mechanism and effect often leads formulators toward a profile that turns out to be incompatible with their processing conditions.
Format compatibility should be established first because it eliminates candidates before you even look at effects. This alone prevents the most common and most preventable mismatch.
Start with Format Compatibility
Your format determines which boiling point ranges are viable in your finished product. This step narrows the field significantly before any other variable comes into play.
For high-temp concentrate processing, decarboxylation, and CO2 extraction, plan for the loss of virtually all monoterpenes unless they’re re-added post-extraction. This means sesquiterpene-dominant profiles (high caryophyllene, high humulene) carry the most consistent effect contribution through processing.
For low-temp vape applications, the full monoterpene range is viable, and high-myrcene, high-linalool, and high-terpinolene profiles perform at their best. For edibles and gummies, emulsification-stable terpenes, limonene, β-caryophyllene, geraniol, and valencene survive better through typical production temperatures.
For topicals, thermally stable sesquiterpenes dominate, with bisabolol and nerolidol adding value for skin applications specifically.
Map Mechanism to Product Positioning
Once format compatibility is established, mechanism-to-positioning alignment narrows the field to what fits your product strategy.
- Daytime/energy-Adjacent: Limonene + α-pinene profiles, low myrcene. Adenosine A2A + AChE inhibition supports alertness and mood without sedative contribution.
- Evening/relaxation: Myrcene + linalool + β-caryophyllene. GABA + CB2 pathway coverage with compounded sedative character.
- Anti-Inflammatory/wellness: Caryophyllene-forward profiles with humulene as secondary. CB2 + NF-κB dual pathway activity provides the strongest anti-inflammatory signal available in cannabis terpene chemistry.
One important compliance note is that mechanism data is useful for internal formulation strategy and for understanding what your product does. It is not the same as a consumer-facing efficacy claim. Keep those distinct in your product development process.
How Terpene Belt Farms Supports Formulators Working from Real Data
The chart in this article is only as useful as the terpene data feeding into your formulation decisions. When a CDT profile ships with COA data that covers only the top five compounds and leaves the minor terpene layer unverified, the chart becomes approximate at best. The boiling point of nerolidol or the NF-κB activity of humulene doesn’t matter if you can’t confirm that those compounds are actually present in the concentration your formulation requires.
Terpene Belt Farms exists for formulators who need that data to hold up. Every Fresh Never Frozen profile is extracted from California-grown hemp using a methodology designed to preserve the complete volatile fraction from the dominant monoterpenes down to the trace compounds in the extended chart above.
The COAs reflect what was actually extracted, not what the genetics might theoretically produce, and that traceability carries through to batch-to-batch consistency because the supply chain is vertically integrated from cultivation to extraction.
For R&D teams moving from bench testing to scale, that consistency is what makes the difference between a product that performs predictably and one that requires reformulation every time a new batch arrives.
Your finished product is only going to be as good as the quality of terpenes in it. Request a sample kit from Terpene Belt Farms today to see how we can help your formulations succeed.
Frequently Asked Questions About the Terpene Effects Chart
Which Terpene Has the Strongest Research Support for Anti-Anxiety Effects?
β-Caryophyllene (CB2 receptor pathway), linalool (GABA-A modulation), and limonene (adenosine A2A and dopamine) all have documented anxiolytic activity. Limonene currently has the strongest human clinical basis, with a 2024 double-blind study from Johns Hopkins and the University of Colorado showing that vaporized limonene significantly reduced THC-induced anxiety in healthy adults. Linalool has strong preclinical backing via GABA-A mechanisms. β-Caryophyllene has robust anti-inflammatory and analgesic data with anxiolytic effects documented as secondary.
How Do Terpene Boiling Points Affect Formulation?
Boiling point determines how much of a terpene survives your production process and is actually present in the finished product. Monoterpenes like myrcene (~167°C) and ocimene (~50–66°C) degrade rapidly during high-temp concentrate processing and standard vape hardware temperatures. Sesquiterpenes like β-caryophyllene (~310°C) and humulene survive those same conditions. Formulating without accounting for boiling points leads to finished products with a different terpene profile — and therefore different effect behavior — than the input COA suggests.
What Makes Β-Caryophyllene Different from Other Cannabis Terpenes?
β-Caryophyllene is the only terpene in cannabis classified as a dietary cannabinoid because it directly agonizes the CB2 cannabinoid receptor. Every other terpene on this chart works through non-cannabinoid receptor pathways — GABA-A, adenosine, NF-κB, AChE. β-Caryophyllene acts directly on the endocannabinoid system’s CB2 receptor, which is associated with peripheral anti-inflammatory and analgesic activity, without producing psychoactive effects via CB1.
Are Terpene Effects the Same Across All Product Formats?
No. Delivery format affects both bioavailability and how terpenes interact with receptor systems. Inhalation delivers terpenes rapidly via lung absorption with high bioavailability. Oral/edible delivery routes terpenes through the digestive system and first-pass hepatic metabolism, which can modify terpene concentrations and, in some cases, metabolite activity. Topical delivery keeps terpene activity localized rather than systemic. High-stability sesquiterpenes like β-caryophyllene and humulene are viable across all formats; many monoterpenes are not.
What Is the Entourage Effect and How Does It Relate to Profile Selection?
The entourage effect refers to the theory that terpenes and cannabinoids interact synergistically to produce effects that differ from what each compound would produce in isolation. The clearest clinical evidence supporting it is the 2024 Johns Hopkins study showing that limonene + THC produced meaningfully reduced anxiety compared to THC alone. In terms of profile selection, this means choosing a CDT profile is not just about picking terpenes based on their individual effect data — it’s about selecting a combination where the interactions between compounds align with your intended product positioning.
Sources Used for This Article
- PNAS: “The phytocannabinoid Δ9-tetrahydrocannabivarin can decrease body weight and increase energy expenditure in mice” – pnas.org/doi/10.1073/pnas.0803601105
- Frontiers: “A Common Molecular Mechanism Underlies the Antidepressant Effects of Regular Exercise and Deep Brain Stimulation” – frontiersin.org/journals/behavioral-neuroscience/articles/10.3389/fnbeh.2018.00241/full
- National Center for Biotechnology Information: “Minor cannabinoids and terpenes: Preclinical and clinical evidence for their therapeutic potential” – pmc.ncbi.nlm.nih.gov/articles/PMC11031290/
- National Center for Biotechnology Information: “The Effect of Alpha-Pinene on Neuroinflammation and Oxidative Stress” – pmc.ncbi.nlm.nih.gov/articles/PMC9319952/
- PubMed: “The therapeutic potential of cannabis and cannabinoids” – pubmed.ncbi.nlm.nih.gov/17559833/
- ScienceDirect: “Pinene” – sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/pinene
